Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Smoore International Holdings Limited (SMORF)
Shenzhen, CN
Smoore International Holdings Limited operates as an investment holding company, primarily dedicated to providing cutting-edge vaping technology solutions. The company is engaged in the full lifecycle of closed-system vaping devices and their components, from research and design to manufacturing, supplying these products to both established tobacco companies and independent vaping businesses. Additionally, Smoore caters to individual consumers by offering open-system vaping hardware under its recognized Vaporesso and FEELM brands. Its market footprint is extensive, covering regions such as Hong Kong, mainland China, the United States, the United Kingdom, France, Japan, and Switzerland, alongside a broader global presence. The firm was founded in 2009 and its corporate headquarters are located in Shenzhen, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +32.08% | +32.08% | +12.00% | -34.88% | -80.14% | -82.28% | -82.28% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Tobacco: +5.3%+17.7% ★ Q4'25: +34.1% (vs Q4'23)
-
EPS growth Tobacco: +18.8%-19.1% Q4'25: -41.4% (vs Q4'23)
-
FCF margin FCF growth · Tobacco: +9.5%-2.6% Q4'25: -2.4% (vs Q4'23)
-
EBIT margin Tobacco: +20.5%+7.7% Q4'25: +8.3% (vs Q4'23)
-
ROIC Tobacco: +16.0%+5.8% Q4'25: +14.9% (vs Q4'23)
-
Share dilution Tobacco: +0.0%+1.2% Q4'25: +1.2% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Tobacco: 0.25×1.65× ★ Q4'25: 0.68× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 7 Rev. Ana. 1 EPS Ana. |
Dec 2027 7 Rev. Ana. 1 EPS Ana. |
Dec 2028 4 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
10.01B
est: 1.65B (+506.1%)
|
13.76B
est: 2.18B (+531.7%)
|
12.14B
est: 12.13B (+0.1%)
|
11.17B
est: 11.30B (-1.2%)
|
11.80B
est: 11.92B (-1.0%)
|
13.89B
est: 14.03B (-1.0%)
|
17.17B
15.65B – 18.67B
+22.3% YoY
|
19.87B
18.03B – 23.11B
+15.7% YoY
|
22.66B
20.60B – 25.56B
+14.0% YoY
|
| EBITDA |
3.19B
est: 506.46M (+529.7%)
|
6.32B
est: 667.75M (+846.8%)
|
3.21B
est: 3.84B (-16.6%)
|
2.24B
est: 3.58B (-37.6%)
|
1.98B
est: 2.83B (-30.2%)
|
1.35B
est: 3.34B (-59.5%)
|
4.08B
3.72B – 4.44B
+22.3% YoY
|
4.72B
4.29B – 5.49B
+15.7% YoY
|
5.39B
4.90B – 6.08B
+14.0% YoY
|
| EBIT |
3.13B
est: 487.14M (+543.2%)
|
6.23B
est: 642.28M (+870.7%)
|
2.98B
est: 3.70B (-19.4%)
|
1.96B
est: 3.45B (-43.0%)
|
1.69B
est: 2.61B (-35.2%)
|
1.07B
est: 3.08B (-65.0%)
|
3.76B
3.43B – 4.09B
+22.3% YoY
|
4.35B
3.95B – 5.06B
+15.7% YoY
|
4.96B
4.51B – 5.60B
+14.0% YoY
|
| Net Income |
2.40B
est: 576.99M (+315.9%)
|
5.29B
est: 866.17M (+510.4%)
|
2.51B
est: 2.84B (-11.5%)
|
1.65B
est: 1.64B (+0.5%)
|
1.30B
est: 1.38B (-5.8%)
|
1.04B
est: 1.16B (-10.5%)
|
1.46B
1.28B – 1.70B
+25.8% YoY
|
2.12B
1.87B – 2.47B
+45.4% YoY
|
2.51B
2.21B – 2.93B
+18.5% YoY
|
| SGA |
899.84M
est: 149.75M (+500.9%)
|
1.06B
est: 197.44M (+435.2%)
|
1.54B
est: 1.11B (+37.8%)
|
1.39B
est: 1.04B (+34.3%)
|
1.83B
est: 1.51B (+21.5%)
|
2.08B
est: 1.78B (+17.1%)
|
2.17B
1.98B – 2.36B
+22.3% YoY
|
2.52B
2.28B – 2.93B
+15.7% YoY
|
2.87B
2.61B – 3.24B
+14.0% YoY
|
| EPS |
0.44
est: 0.09 (+370.3%)
|
0.89
est: 0.14 (+533.7%)
|
0.42
est: 0.46 (-8.7%)
|
0.27
est: 0.27 (+1.3%)
|
0.21
est: 0.22 (-5.6%)
|
0.17
est: 0.19 (-8.8%)
|
0.23
0.21 – 0.27
+25.8% YoY
|
0.34
0.30 – 0.40
+45.4% YoY
|
0.40
0.36 – 0.47
+18.5% YoY
|
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Zhiping Chen | Chief Executive Officer & Chairman of the Board | 1M | male |
| Guisheng Wang CICPA | Chief Financial Officer, Executive Director & Joint Company Secretary | 623.5K | male |
| Xin Wang | Executive Director | 255.8K | female |
| Shaoming Xiong | Executive Director & Vice GM | 189.8K | male |
| Baosheng Lai | Group Vice President & Group President of APV Business | — | male |
| Weidong Pan | General Manager of Technology Center | — | male |
| Chunhua Luo | General Manager of Operation Department | — | male |
| Choi Ha Cheng | Joint Company Secretary | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SMORF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
